Turnstone Biologics Corp Stock Today
| TSBX Stock | 0.52 0.01 1.96% |
Performance0 of 100
| Odds Of DistressOver 67
|
Turnstone Biologics is trading at 0.52 as of the 30th of November 2024; that is 1.96 percent up since the beginning of the trading day. The stock's open price was 0.51. Turnstone Biologics has more than 67 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Turnstone Biologics Corp are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 31st of October 2024 and ending today, the 30th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 21st of July 2023 | Category Healthcare | Classification Health Care |
Turnstone Biologics is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 23.13 M outstanding shares of which 702.88 K shares are at this time shorted by private and institutional investors with about 2.36 trading days to cover. More on Turnstone Biologics Corp
Moving against Turnstone Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Turnstone Stock Highlights
| CEO President | Dr MBA | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turnstone Biologics can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Turnstone Biologics' financial leverage. It provides some insight into what part of Turnstone Biologics' total assets is financed by creditors. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Turnstone Biologics Corp (TSBX) is traded on NASDAQ Exchange in USA. It is located in 9310 Athena Circle, La Jolla, CA, United States, 92037 and employs 80 people. Turnstone Biologics is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 13.39 M. Turnstone Biologics Corp conducts business under Biotechnology sector and is part of Health Care industry. The entity has 23.13 M outstanding shares of which 702.88 K shares are at this time shorted by private and institutional investors with about 2.36 trading days to cover.
Turnstone Biologics generates negative cash flow from operations
Check Turnstone Biologics Probability Of Bankruptcy
Ownership AllocationTurnstone Biologics Corp shows a total of 23.13 Million outstanding shares. Over half of Turnstone Biologics' outstanding shares are owned by institutional holders. These institutional holders are typically referred to as corporate investors that take positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Turnstone Ownership Details
Turnstone Biologics Historical Income Statement
Turnstone Stock Against Markets
Turnstone Biologics Corporate Management
| Ines MD | Senior Development | Profile | |
| Michael Fitch | Senior Manufacturing | Profile | |
| Vijay MBA | Interim Officer | Profile | |
| Campisi Esq | Chief Officer | Profile | |
| David Stojdl | Senior Discovery | Profile |
Additional Tools for Turnstone Stock Analysis
When running Turnstone Biologics' price analysis, check to measure Turnstone Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Turnstone Biologics is operating at the current time. Most of Turnstone Biologics' value examination focuses on studying past and present price action to predict the probability of Turnstone Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Turnstone Biologics' price. Additionally, you may evaluate how the addition of Turnstone Biologics to your portfolios can decrease your overall portfolio volatility.